Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases

The incretin hormone glucagon-like peptide 1 (GLP-1) has many effects in the body. It is best known for the ‘incretin effect’, facilitating insulin release from the pancreas under hyperglycaemic conditions. Building on this, GLP-1 mimetics have been developed as a treatment for type 2 diabetes. In t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of endocrinology 2014-04, Vol.221 (1), p.T31-T41
1. Verfasser:	Hölscher, Christian
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Glucagon-Like Peptide 1 - therapeutic use Humans Neurodegenerative Diseases - drug therapy Neuroprotective Agents - therapeutic use Thematic Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!